Celgene’s multiple myeloma treatment has been approved by the US FDA. Pomalyst has been approved to treat patients with this form of blood cancer whose disease progressed after being treated ...

Celgene has managed to get its Imnovid past NICE at the second attempt for multiple myeloma, thanks to new data comparing it with rival treatments and competitive pricing. NICE rejected Imnovid ...

Multiple myeloma (MM), which is caused by the transformation ... diagnosed with MM in combination with melphalan (Alkeran; Celgene) and prednisone. This combination, also known as VMP, produced ...

offered a new oral drug option to the group of people suffering from multiple myeloma. Celgene Corporation (Nasdaq: CELG) announced that the U.S. Food and Drug Administration (FDA) has granted ...

Myeloma develops due to the accumulation of multiple pathological genetic events ... KD Boyd has been involved in Celgene speaker bureaus. C Pawlyn has received conference travel support from ...

the future of myeloma therapy will involve genotyping of individual patient tumors, and designing therapy based on the results. Therapy will become bespoke, targeting the multiple deregulated ...